If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 25.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 5.00 (20.00%)
Open: 27.50
High: 27.50
Low: 27.50
Prev. Close: 27.50
KRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Debt Facility

19 Jun 2023 07:00

RNS Number : 0729D
KRM22 PLC
19 June 2023
 

KRM22 plc

("KRM22", the "Group" or the "Company")

New Debt Facility

 

KRM22 plc (AIM: KRM.L), the technology and software investment company, with a particular focus on risk management in capital markets, is pleased to announce that, after a competitive process, it has entered into an agreement for a new £5.0m convertible loan facility (the "Facility") arranged by Trading Technologies International, Inc. ("TT"), the Company's largest shareholder. The Company will draw down an initial amount of £4.0m under the Facility on satisfaction of the conditions precedent set out in the loan agreement in a single tranche and will replace the Company's existing debt facility provided by certain affiliates of Kestrel Partners LLP ("Kestrel"). It is intended that the balance of the outstanding debt and charges of approximately £3.1m under the existing Kestrel debt facility will be repaid early using the proceeds of the Facility.

 

The Facility is being provided to strengthen the Company's balance sheet and access both working capital and growth capital in order to support the short to mid-term opportunities available to the Company.

 

Terms of the Facility

The Facility will be for a maximum of £5.0m and will be secured on certain Group assets and includes covenants based on the Group's financial performance, based on annualised recurring revenue, recognised revenue and solvency and will also be guaranteed by certain members of the Group.

 

The interest rate payable on debt drawn down is the aggregate of the SOFR average and a margin of 5.5 per cent. provided that the minimum amount per annum of such aggregate percentage rate per annum shall be 9.25 per cent. The interest will be payable quarterly in arrears however the Company has the ability to defer interest payments for the initial 18 months (the "Initial Interest Period"), with the total deferred interest in the Initial Interest Period being paid in two equal instalments on the calendar quarters ending after the 18th and 21st month anniversary of the Facility. The Facility carries an arrangement fee of 1 per cent. of the amount of debt drawn down payable by deduction/retention from the drawn proceeds. The term of the Facility is 3 years with the option to extend by a further year to 4 years.

 

Immediately following entry into the Facility TT can request conversion of the Facility into up to a maximum number of 3,566,630 new ordinary shares in the Company at any time at the lowest conversion price of: £0.46; the volume weighted average price of the Company's ordinary shares for the 3 month period prior to service of conversion notice; or the lowest daily closing price for the 30 completed calendar days prior to service of conversion notice. TT has the right to prevent any conversion which would trigger a Rule 9 event under the Takeover Code.

 

Pursuant to the Facility, the Company has agreed that it will as soon as practicable convene a general meeting to approve the allotment of new ordinary shares sufficient to convert the full amount of the Facility at the conversion price set out above. Full conversion of the Facility at a conversion price of £0.46 would result in the issue of 10,869,565 new ordinary shares to TT. If the Company's share price falls below £0.46 then conversion of the Facility could result in the issue of a greater number of shares. Pursuant to Rule 9 of the Takeover Code, TT cannot acquire 30 per cent or more of the voting rights in the Company without being required to make a mandatory cash offer for all the shares in the Company not already held by it. No waiver from Rule 9 is being sought in connection with the conversion right under the Facility.

 

 

Related Party Transaction

TT is considered a "related party" as defined under the AIM Rules as a result of its substantial shareholding of 25.0 per cent. in the Company. The provision of the Facility by TT constitutes a related party transaction for the purposes of Rule 13 of the AIM Rules.

 

The Independent Directors, being Stephen Casner, Kim Suter, Garry Jones, Sandy Broderick and Steve Sparke, consider, having consulted with the Company's nominated adviser for the purposes of the AIM Rules, finnCap, that the terms of the Facility are fair and reasonable insofar as the Company's shareholders are concerned.

 

Stephen Casner, Chief Executive Officer commented: 

 

"We are very pleased to announce this new debt facility which will continue to fuel the strong revenue growth that KRM22 has experienced over the past 18 months. Trading Technologies continues to demonstrate what an exceptional partner they are for KRM22 as together we bring a new generation of risk systems to the capital markets industry."

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

For further information please contact:

 

KRM22 plc InvestorRelations@krm22.com

Keith Todd CBE, Executive Chairman

Stephen Casner, CEO

Kim Suter, CFO

 

finnCap Ltd (Nominated Adviser and Broker) +44 (0)20 7220 0500

Carl Holmes / George Dollemore

Alice Lane / Sunila de Silva (ECM)

 

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' trading and corporate risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at www.krm22.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBGGDLRSBDGXI
Date   Source Headline
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
13th Jan 20217:00 amRNSIssue of Options
12th Jan 20217:00 amRNSTrading Update
5th Oct 20207:00 amRNSIssue of Options
21st Sep 20208:33 amRNSIssue of Options
18th Sep 20209:26 amRNSHolding(s) in Company
16th Sep 20207:00 amRNSNew Debt Facility
16th Sep 20207:00 amRNSInterim Results
17th Aug 20207:00 amRNSNew Customer Contract
23rd Jul 202010:49 amRNSIssue of Options
21st Jul 20207:00 amRNSTrading Update
3rd Jul 20201:37 pmRNSHolding(s) in Company
29th Jun 20207:00 amRNSConversion of Convertible Loan Note
25th Jun 202011:51 amRNSResult of AGM
2nd Jun 20207:00 amRNSNotice of AGM and Posting of Annual Report
27th May 20207:00 amRNSSubscription
21st May 20207:00 amRNSAUDITED RESULTS FOR THE YEAR ENDED 31 DEC 2019
20th May 20204:41 pmRNSHolding(s) in Company
19th May 20207:00 amRNSHolding(s) in Company
18th May 20208:53 amRNSHolding(s) in Company
14th May 20207:00 amRNSCompletion of Equity Fundraising
11th May 20207:00 amRNSUpdate on Equity Fundraising
7th May 20202:47 pmRNSStatement re. share price movement
17th Apr 20207:00 amRNSConsolidation of ownership of Irisium Ltd
2nd Apr 20207:00 amRNSDirectorate Changes
2nd Apr 20207:00 amRNSTrading Update
13th Jan 20204:30 pmRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSTrading Update
3rd Dec 20197:00 amRNSDirectorate Changes
20th Nov 20198:03 amRNSKRM22 announces Market Risk solution for the GRP
14th Nov 20195:23 pmRNSHolding(s) in Company
7th Nov 20197:01 amRNSKRM22 announces partnership with deltaconX
7th Nov 20197:00 amRNSPlacing
31st Oct 20197:00 amRNSBusiness Update
3rd Oct 20197:00 amRNSNew customer contract
24th Sep 20194:40 pmRNSSecond Price Monitoring Extn
24th Sep 20194:35 pmRNSPrice Monitoring Extension
17th Sep 20197:00 amRNSInterim Results
11th Sep 20197:00 amRNSTrading Update and Notice of Interim Results
6th Aug 20197:00 amRNSKRM22 adds Digital Client Onboarding to offering
11th Jul 20197:00 amRNSPartnership with Quant Foundry
11th Jul 20197:00 amRNSHalf Year Trading Update
28th Jun 201911:52 amRNSResult of AGM
25th Jun 201910:17 amRNSHolding(s) in Company
19th Jun 20197:00 amRNSPartnership with Neotas
6th Jun 20199:00 amRNSNotice of AGM & Posting of Annual Report
6th Jun 20197:00 amRNSSubscription
5th Jun 20196:13 pmRNSHolding(s) in Company
3rd Jun 20197:01 amRNSDirector role change
3rd Jun 20197:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.